Analytics

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

The high-profile case of contaminated heparin from a Chinese supplier has intensified the debate on the effectiveness of FDA's process for inspecting foreign drug-manufacturing facilities. The article examines proposed legislative and regulatory reforms and actions taken by the agency to improve drug-import safety.

The Anatomy of the Changing Supply Chain

Also, Cobra Biomanufacturing to extend collaboration and form joint venture with ViroMed, Epix Pharmaceuticals CEO resigns, more...

Company and People Notes: Sanofi Pasteur to Acquire Acambis, West Appoints Matthew T. Mullarkey As COO, More...

Senator Sherrod Brown sent a letter to Richard T. Clark, president and chief executive officer of Merck (Whitehouse Station, NJ), to ask for information about the company's reliance on global outsourcing for the manufacture of pharmaceutical ingredients and finished products.

Senator Brown Requests Information about Merck's Outsourcing Procedures

Also, Roche to end HIV/AIDS research program, WuXi PharmaTech makes appointments, more...

Company and People Notes: Solvay Pharma Raises Bid for Innogenetics, Catalent Appoints VP of Printed Components, More...

Also, Pall plans expansion in South America, Anthony Clarke joins Alexza Pharmaceuticals, more...

Company and People Notes: BMS to Acquire Kosan, L. Patrick Gage Resigns from PDL, More...

The European Federation of Pharmaceutical Industries and Associations (EFPIA), the trade association representing European pharmaceutical manufacturers, issued recommendations to the public consultation launched in March by the European Commission's proposed drug anticounterfeiting measures. EFPIA's proposal includes a ban on drug repackaging.

EFPIA Recommends Drug Anticounterfeiting Measures

Also, FDA removes OAI status for Watson's Florida facility, executive management changes as GSK, more...

Company and People Notes: Actavis Totowa Recalls "Digitek," Cynthia Schwalm Named President of Eisai Inc., More

Angie Drakulich was editorial director of Pharmaceutical Technology.

The US Food and Drug Administration issued a final guidance last week regarding investigational new drug applications for human gene therapy.

Gene Therapy CMC Guidance Released

Also, Alcon plans to open Singapore facility, Pharmacopeia president and CEO retired, more...

Company and People Notes: Roche to Acquire Piramed for $160 Million, Adventrx Pharma Appoints Jose Hechavarria VP of Manufacturing, More

Also, VaxGen and Raven terminate merger agreement, Darren Head appointed CEO of Cytovance, more...

Drug Substance Analysis